x min read

Isodiol International Inc (OTCMKTS:ISOLF) On A Trajectory Higher

Isodiol International Inc (OTCMKTS:ISOLF) On A Trajectory Higher
Written by
Jim Bloom
Published on
September 24, 2018
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

There is no mistaking that marijuana stocks have become the new gems of the stock exchange. Marijuana companies and their affiliates have been rising throughout the 2017/18 period, providing investors with thousand-percentage returns on their share price and continued increases in profits. Moreover, their growth potential stemming from the continued legalization of cannabis and its by-products across the globe by countries and institutions provides investors with an unlimited upside potential, one in which investors are working daily to exploit.One such company is Isodiol International Inc (OTCMKTS:ISOLF). With a market capitalization of $134 million, the company has continued to provide investors with consecutive returns through higher profits every year. With this year’s financials not differing from the aforementioned trend, the company’s share price has been on an upward trajectory, scaling the ladder to a price of $3.4 from lows of $2.5 in just five days as shown in the chart below: ISOLF Daily ChartISOLF has further continued to forge new partnerships with different brands and investors in a bid to ensure that they continue to boost shareholder value. This report looks at their most recent partnerships and evaluates how they have and will continue to impact the company’s share price and total returns in future; providing investors with an outlook on the company’s growth potential.

Isodiol International: The Past and Present

Before going into the details, however, let us have a look at the company’s history for the sake of first-time readers.Founded in 2014 and headquartered in Vancouver, Canada, Isodiol International Inc is a leading manufacturer and developer of phytoceutical products. The firm produces both nutraceutical and pharmaceutical compounds and prides itself on being the market leader in the commercialization of novel cannabis industry products. These include the nanotechnology-based skin care products, cannabinoids - pharmaceutical grade – which they postulate are 99%+ pure.Over time, the firm has maintained its expansionary strategy, growing their market share across continents. They have ventured into South America, Asia, and Europe, all in a bid to ensure they grow their market share as well as revenue. Furthermore, their product base has been growing over time courtesy of the research and development they have chosen to invest in. All in all, the firm’s meticulous product development and aggressive expansionary strategy have been attributed as the reason for their growth. This, however, hasn’t been the end.

ISOLF: The Past Month

From the latter, it is clear that ISOLF is the gift that keeps on giving. Their share price - $3.4 – as well as their profits continue to attract investors to their front. There has therefore been a lot the company has been doing to maintain their position in the market.Since our last review – which readers can access here – as well as since August, ISOLF has had numerous announcements regarding their board of directors, new products and partnerships as well as their financial information; all which are discussed below.

The New Board Members

Following the departure of the firm’s President of the Board, Soheil Samimi, the board of directors of ISOLF announced the appointment of Mr. Patrick Ogle as the company’s Chief Operating Officer and a member of the Board of Directors.Mr. Ogle brings to the board has acted as the general counsel for numerous listed companies as well as been the founder of companies operating within the beverage, mining and apparel segments over a period of two decades. Throughout this period, he has maintained an outstanding success rate, transforming the companies which he has led. He has also been pivotal to the success of ISOLF as expressed by ISOLF’s CEO, Marcos Agramont:

"Aside from his legal work for Isodiol, he has been involved in onboarding many of our subsidiaries' operational teams since their acquisition by Isodiol and is a natural fit with the Company.”

Source:In his new capacity, Mr. Ogle is expected to ensure that the firm meets their onboarding and operational targets while maintaining their current financial success trail.

Kathy Ireland Branded Products

In line with their partnership strategy, ISOLF decided to launch five of their cannabis products under the Kathy Ireland Health and Wellness brand. Back in January, ISOLF announced then a 10-year licensing agreement with Level Brands, the company headed by Kathy Ireland. The launch of the new products, despite having a greater impact on Level Brands’ stock, means that ISOLF continues to benefit from higher marketing, therefore, higher sales and shareholder value at the end of the period.Given the positive impact the brand partnership has had thus far, it is expected that ISOLF will benefit greatly both in their sales and market share.

Financial Performance

The best news yet came in mid-September when ISOLF announced better financial performance. The firm’s first-quarter revenue stood at $9.2 million, rising by 240% from their revenue position in the previous quarter ended June 2018. The other revenues segment also grew by 70% to $5.4 million. Furthermore, their cash position stood at $11.5 million, ensuring that the firm would continue to sustain their working capital needs effectively.The above news, in addition to the binding agreements which they had signed with other marijuana cultivating entities – such as Farmtiva and Round Mountain Technologies – spoke to their ability to sustain their growth position and would see their share price surge as it did.Eventually, it boiled down to the company’s current and future growth, all of which seem to be catered to given the current position. As such, growth seems imminent for ISOLF in the near and distant future.

Conclusion

Given the current financial position and partnerships coupled with the firm’s growth capacity, ISOLF seems to be on the path towards the green zone. We remain positive about their future returns.We will be updating our subscribers as soon as we know more. For the latest updates on ISOLF, sign up below!Disclosure: We have no position in ISOLF and have not been compensated for this article.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.